1: Pasten C, Lozano M, Méndez GP, Irarrázabal CE. 1400W Prevents Renal Injury in
the Renal Cortex But Not in the Medulla in a Murine Model of Ischemia and
Reperfusion Injury. Cell Physiol Biochem. 2022 Oct 19;56(5):573-586. doi:
10.33594/000000577. PMID: 36259161.
2: Shi Q, Liu X, Wang N, Zheng X, Ran J, Liu Z, Fu J, Zheng J. 1400W ameliorates
acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing
the induction of inducible nitric oxide synthase in rat cerebral cortex
microglia. Behav Brain Res. 2017 Feb 15;319:188-199. doi:
10.1016/j.bbr.2016.11.039. Epub 2016 Nov 22. PMID: 27888018.
3: Putra M, Vasanthi SS, Rao NS, Meyer C, Van Otterloo M, Thangi L, Thedens DR,
Kannurpatti SS, Thippeswamy T. Inhibiting Inducible Nitric Oxide Synthase with
1400W Reduces Soman (GD)-Induced Ferroptosis in Long-Term Epilepsy-Associated
Neuropathology: Structural and Functional Magnetic Resonance Imaging
Correlations with Neurobehavior and Brain Pathology. J Pharmacol Exp Ther. 2024
Jan 17;388(2):724-738. doi: 10.1124/jpet.123.001929. PMID: 38129129; PMCID:
PMC10801728.
4: Puttachary S, Sharma S, Verma S, Yang Y, Putra M, Thippeswamy A, Luo D,
Thippeswamy T. 1400W, a highly selective inducible nitric oxide synthase
inhibitor is a potential disease modifier in the rat kainate model of temporal
lobe epilepsy. Neurobiol Dis. 2016 Sep;93:184-200. doi:
10.1016/j.nbd.2016.05.013. Epub 2016 May 18. PMID: 27208748.
5: Hosgood SA, Yates PJ, Nicholson ML. 1400W reduces ischemia reperfusion injury
in an ex-vivo porcine model of the donation after circulatory death kidney
donor. World J Transplant. 2014 Dec 24;4(4):299-305. doi: 10.5500/wjt.v4.i4.299.
PMID: 25540738; PMCID: PMC4274599.
6: Putra M, Sharma S, Gage M, Gasser G, Hinojo-Perez A, Olson A, Gregory-Flores
A, Puttachary S, Wang C, Anantharam V, Thippeswamy T. Inducible nitric oxide
synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the
rat model. Neurobiol Dis. 2020 Jan;133:104443. doi: 10.1016/j.nbd.2019.03.031.
Epub 2019 Mar 30. PMID: 30940499; PMCID: PMC6768773.
7: Vasanthi SS, Rao NS, Samidurai M, Massey N, Meyer C, Gage M, Kharate M,
Almanza A, Wachter L, Mafuta C, Trevino L, Carlo AM, Bryant E, Corson BE,
Wohlgemuth M, Ostrander M, Wang C, Thippeswamy T. Disease-Modifying Effects of a
Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex
Cohorts of a Rat Soman (GD) Model of Epilepsy. Res Sq [Preprint]. 2023 May
8:rs.3.rs-2883247. doi: 10.21203/rs.3.rs-2883247/v1. Update in: J
Neuroinflammation. 2023 Jul 12;20(1):163. doi: 10.1186/s12974-023-02847-1. PMID:
37214912; PMCID: PMC10197763.
8: Schnichels S, Joachim SC. The inducible nitric oxide synthase-inhibitor 1400W
as a potential treatment for retinal diseases. Neural Regen Res. 2021
Jun;16(6):1221-1222. doi: 10.4103/1673-5374.300445. PMID: 33269785; PMCID:
PMC8224120.
9: Gao Y, Zhou S, Xu Y, Sheng S, Qian SY, Huo X. Nitric oxide synthase
inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.
Nitric Oxide. 2019 Feb 1;83:33-39. doi: 10.1016/j.niox.2018.12.008. Epub 2018
Dec 24. PMID: 30590117; PMCID: PMC6677402.
10: Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles
RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible
nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997 Feb
21;272(8):4959-63. doi: 10.1074/jbc.272.8.4959. PMID: 9030556.